Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Comprehensive care programme for patients with chronic obstructive pulmonary disease: a randomised controlled trial [with consumer summary]
Ko FWS, Cheung NK, Rainer TH, Lum C, Wong I, Hui DSC
Thorax 2017 Feb;72(2):122-128
clinical trial
5/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: No; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

BACKGROUND: There have been no randomised controlled trials that specifically evaluate the effect of a comprehensive programme with multidisciplinary input on patients who have just been discharged from hospital after treatment of acute exacerbation of COPD (AECOPD). The aim of this study was to assess whether a comprehensive care programme would decrease hospital readmissions and length of hospital stay (LOS) for patients with COPD. METHODS: Patients discharged from hospital after an episode of AECOPD were randomised to an intervention group (IG) or usual care group (UG). The IG received a comprehensive, individualised care plan which included education from a respiratory nurse, physiotherapist support for pulmonary rehabilitation, 3-monthly telephone calls by a respiratory nurse over 1 year, and follow-up at a respiratory clinic with a respiratory specialist once every 3 months for 1 year. The UG were managed according to standard practice. The primary outcome was hospital readmission rate at 12 months. RESULTS: 180 patients were recruited (IG, n = 90; UG, n = 90; mean +/- SD age 74.7 +/- 8.2 years, 172 (95.6%) men; mean +/- SD FEV1 45.4 +/- 16.6% predicted). At 12 months, the adjusted relative risk of readmission was 0.668 (95% CI 0.449 to 0.995, p = 0.047) for the IG compared with the UG. At 12 months, the IG had a shorter LOS (4.59 +/- 7.16 versus 8.86 +/- 10.24 days, p <= 0.001), greater improvement in mean Modified Medical Research Council Dyspnoea Scale (-0.1 +/- 0.6 versus 0.2 +/- 0.6, p = 0.003) and St George's Respiratory Questionnaire score (-6.9 +/- 15.3 versus -0.1 +/- 13.8, p = 0.003) compared with the UG. CONCLUSIONS: A comprehensive COPD programme can reduce hospital readmissions for COPD and LOS, in addition to improving symptoms and quality of life of the patients. TRIAL REGISTRATION NUMBER: NCT01108835, results.
Reproduced with permission from the BMJ Publishing Group.

Full text (sometimes free) may be available at these link(s):      help